Jale Muslehiddinoglu is Scientific Director at Johnson& Johnson, where she leads DS development efforts for oligonucleotide portfolio.
Jale joined J&J in 2015. She has 18 years of experience in biopharmaceutical industry in various functions within DS from early stage to late stage and commercialization. She holds a Ph.D. in chemical engineering from The Pennsylvania State University.
Tuesday, November 3, 2020
9:30 AM – 10:00 AM ET